Yong Xiang Wang

Charter Medical has an established history of providing specialty products to the blood transfusion and cell therapies and single-use bioprocessing containers to the biotechnology and pharmaceutical markets. Charter Medical was formed in 1998, a privately held medical device manufacturer of disposable blood transfusion and intravenous products located in Lakewood, NJ. Charter Medical continued production of the existing CharterMed medical devices and expanded the product line to include bioprocessing bags. Manufacturing began at the Winston-Salem headquarters in 1998 in one ISO Class 8 cleanroom. In 2001, Charter Medical commissioned a second cleanroom at the 71,000 square foot site to expand the medical device and bioprocessing bag manufacturing capabilities. Through a second expansion in 2009, Charter Medical now houses 15,000 square feet of clean room space to support the ever growing demand for disposable products.

Aeras Global TB Vaccine Foundation is a non-profit organization, which engages in the development of tuberculosis vaccines in partnership with other biotech, pharmaceutical, and academic organizations. Its product pipeline includes AdS Ag85A, MTBCAV, VPM 1002, and RUTI. The company is headquartered in Rockville, MD.

Ben Venue Laboratories, Inc. develops and manufactures sterile liquid products. Its products include Lyophilized Dosages, Small Molecule Pharmaceuticals, Cytotoxics, and Potent Compounds. The company was founded by R. Templeton Smith in 1938 and is headquartered in Bedford, OH.

NewLink Genetics Corp. is a late-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of novel immunotherapeutic products to improve cancer treatment options for patients and physicians. The firm's portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a range of oncology indications. It products include HyperAcute Pancreas, HyperAcute Lung, HyperAcute Melanoma, HyperAcute Imunotherapies, NLG8189, and IDO Pathway Inhibitors. The company was founded by Charles J. Link and Nicholas N. Vahanian on June 4, 1999 and is headquartered in Ames, IA.